(19)
(11) EP 4 815 980 A1

(12)

(43) Date of publication:
07.10.2026 Bulletin 2026/41

(21) Application number: 24817200.9

(22) Date of filing: 27.11.2024
(51) International Patent Classification (IPC): 
A61K 39/00(2006.01)
C07K 16/30(2006.01)
A61P 35/04(2006.01)
A61P 35/00(2006.01)
C07K 16/28(2006.01)
(52) Cooperative Patent Classification (CPC):
C07K 16/2803; C07K 2317/31; C07K 16/28; C07K 16/30; A61K 2039/505; C07K 2317/33; C07K 2317/90; C07K 2317/94; A61K 2039/54; A61K 2039/545; A61P 35/00; A61P 35/04; C07K 16/2818; A61K 2039/507; C07K 2317/76
(86) International application number:
PCT/EP2024/083760
(87) International publication number:
WO 2025/114357 (05.06.2025 Gazette 2025/23)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 28.11.2023 US 202363603418 P

(71) Applicant: Novimmune S.A.
1228 Plan-les-Ouates, Geneva (CH)

(72) Inventors:
  • SARO SUAREZ, Jose Maria
    1228 Geneva (CH)
  • FERLIN, Walter G.
    1228 Geneva (CH)

(74) Representative: Haseltine Lake Kempner LLP 
Cheapside House 138 Cheapside
London EC2V 6BJ
London EC2V 6BJ (GB)

   


(54) METHOD OF TREATING DISEASE USING ANTI-CD47 X ANTI-MESOTHELIN ANTIBODIES AS A SOLE AGENT AND IN COMBINATION WITH ANTI-PD-1 ANTIBODIES